Clinical trial registry changes
Status changes, moved primary completion and completion dates, and results first posted on ClinicalTrials.gov, for trials linked to listed companies. Newest detection first.
Newest change detected Nov 19, 2026, 8:47 AM ET
| Detected | Trial | Change | Now | Before | Record updated |
|---|---|---|---|---|---|
| Nov 19, 2026, 8:47 AM ET | Status | Recruiting | Locked | Locked | |
| Nov 19, 2026, 8:47 AM ET | Completion date | Nov 16, 2026 (actual) | Locked | Locked | |
| Nov 19, 2026, 8:47 AM ET | Status | Completed | Locked | Locked | |
| Nov 19, 2026, 8:47 AM ET | Results posted | Results posted to the registry | Locked | Locked | |
| Nov 19, 2026, 8:47 AM ET | Completion date | Dec 23, 2025 (actual) | Locked | Locked | |
| Nov 19, 2026, 8:47 AM ET | Primary completion date | Dec 23, 2025 (actual) | Locked | Locked | |
| Nov 19, 2026, 8:47 AM ET | Status | Completed | Locked | Locked | |
| Nov 19, 2026, 8:47 AM ET | Completion date | Sep 2027 (sponsor estimate) | Locked | Locked | |
| Nov 19, 2026, 8:47 AM ET | Results posted | Results posted to the registry | Locked | Locked | |
| Nov 19, 2026, 8:47 AM ET | Completion date | Oct 24, 2026 (actual) | Locked | Locked | |
| Nov 19, 2026, 8:47 AM ET | Primary completion date | Oct 24, 2026 (actual) | Locked | Locked | |
| Nov 19, 2026, 8:47 AM ET | Status | Completed | Locked | Locked | |
| Nov 19, 2026, 8:47 AM ET | Results posted | Results posted to the registry | Locked | Locked | |
| Nov 19, 2026, 8:47 AM ET | Completion date | Sep 18, 2023 (actual) | Locked | Locked | |
| Nov 19, 2026, 8:47 AM ET | Primary completion date | Sep 18, 2023 (actual) | Locked | Locked | |
| Nov 19, 2026, 8:47 AM ET | Status | Completed | Locked | Locked | |
| Nov 19, 2026, 8:47 AM ET | Results posted | Results posted to the registry | Locked | Locked | |
| Nov 19, 2026, 8:47 AM ET | Primary completion date | Jun 1, 2027 (sponsor estimate) | Locked | Locked | |
| Nov 19, 2026, 8:47 AM ET | Status | Active, not recruiting | Locked | Locked | |
| Nov 19, 2026, 8:47 AM ET | Completion date | Jul 21, 2027 (sponsor estimate) | Locked | Locked | |
| Nov 19, 2026, 8:47 AM ET | Primary completion date | Jul 21, 2027 (sponsor estimate) | Locked | Locked | |
| Nov 19, 2026, 8:47 AM ET | Status | Recruiting | Locked | Locked | |
| Nov 19, 2026, 8:47 AM ET | Completion date | Sep 28, 2026 (actual) | Locked | Locked | |
| Nov 19, 2026, 8:47 AM ET | Primary completion date | Sep 28, 2026 (actual) | Locked | Locked | |
| Nov 19, 2026, 8:47 AM ET | Status | Completed | Locked | Locked |
- Detected Nov 19, 2026, 8:47 AM ETStatusNCT07484139H&N NEO-COMBAT XL: Neoadjuvant XL-092 (Zanzalintinib) and Pembrolizumab (Keytruda) in Surgically Resectable, HPV Negative Oral Cavity...EXEL
- Now
- Recruiting
- Before
- Locked
- Detected Nov 19, 2026, 8:47 AM ETCompletion dateNCT04652076GYNecological Cancers Treated With NETrin mAbs in Combination With Chemotherapy and /or PembrolizumabMRK
- Now
- Nov 16, 2026 (actual)
- Before
- Locked
- Detected Nov 19, 2026, 8:47 AM ETStatusNCT04652076GYNecological Cancers Treated With NETrin mAbs in Combination With Chemotherapy and /or PembrolizumabMRK
- Now
- Completed
- Before
- Locked
- Detected Nov 19, 2026, 8:47 AM ETResults postedNCT05071716Study to Assess Rifaximin Soluble Solid Dispersion (SSD) for the Delay of Encephalopathy Decompensation in CirrhosisBHC
- Now
- Results posted to the registry
- Before
- Locked
- Detected Nov 19, 2026, 8:47 AM ETCompletion dateNCT05071716Study to Assess Rifaximin Soluble Solid Dispersion (SSD) for the Delay of Encephalopathy Decompensation in CirrhosisBHC
- Now
- Dec 23, 2025 (actual)
- Before
- Locked
- Detected Nov 19, 2026, 8:47 AM ETPrimary completion dateNCT05071716Study to Assess Rifaximin Soluble Solid Dispersion (SSD) for the Delay of Encephalopathy Decompensation in CirrhosisBHC
- Now
- Dec 23, 2025 (actual)
- Before
- Locked
- Detected Nov 19, 2026, 8:47 AM ETStatusNCT05071716Study to Assess Rifaximin Soluble Solid Dispersion (SSD) for the Delay of Encephalopathy Decompensation in CirrhosisBHC
- Now
- Completed
- Before
- Locked
- Detected Nov 19, 2026, 8:47 AM ETCompletion date
- Now
- Sep 2027 (sponsor estimate)
- Before
- Locked
- Detected Nov 19, 2026, 8:47 AM ETResults postedNCT05348915A Study to Evaluate the Long-term Safety of Inclacumab Administered to Participants With Sickle Cell DiseasePFE
- Now
- Results posted to the registry
- Before
- Locked
- Detected Nov 19, 2026, 8:47 AM ETCompletion date
- Now
- Oct 24, 2026 (actual)
- Before
- Locked
- Detected Nov 19, 2026, 8:47 AM ETPrimary completion date
- Now
- Oct 24, 2026 (actual)
- Before
- Locked
- Detected Nov 19, 2026, 8:47 AM ETStatus
- Now
- Completed
- Before
- Locked
- Detected Nov 19, 2026, 8:47 AM ETResults posted
- Now
- Results posted to the registry
- Before
- Locked
- Detected Nov 19, 2026, 8:47 AM ETCompletion date
- Now
- Sep 18, 2023 (actual)
- Before
- Locked
- Detected Nov 19, 2026, 8:47 AM ETPrimary completion date
- Now
- Sep 18, 2023 (actual)
- Before
- Locked
- Detected Nov 19, 2026, 8:47 AM ETStatus
- Now
- Completed
- Before
- Locked
- Detected Nov 19, 2026, 8:47 AM ETResults posted
- Now
- Results posted to the registry
- Before
- Locked
- Detected Nov 19, 2026, 8:47 AM ETPrimary completion date
- Now
- Jun 1, 2027 (sponsor estimate)
- Before
- Locked
- Detected Nov 19, 2026, 8:47 AM ETStatus
- Now
- Active, not recruiting
- Before
- Locked
- Detected Nov 19, 2026, 8:47 AM ETCompletion dateNCT07423481Weight Trajectories and Predictive Factors After Semaglutide in Patients With Grade 3 and Complicated ObesityNVO
- Now
- Jul 21, 2027 (sponsor estimate)
- Before
- Locked
- Detected Nov 19, 2026, 8:47 AM ETPrimary completion dateNCT07423481Weight Trajectories and Predictive Factors After Semaglutide in Patients With Grade 3 and Complicated ObesityNVO
- Now
- Jul 21, 2027 (sponsor estimate)
- Before
- Locked
- Detected Nov 19, 2026, 8:47 AM ETStatusNCT07423481Weight Trajectories and Predictive Factors After Semaglutide in Patients With Grade 3 and Complicated ObesityNVO
- Now
- Recruiting
- Before
- Locked
- Detected Nov 19, 2026, 8:47 AM ETCompletion dateNCT07204418A Study to Evaluate the Effects of CYP2D6 Phenotypes on the Pharmacokinetics of Xanomeline Following KarXT Administration in Healthy...BMY
- Now
- Sep 28, 2026 (actual)
- Before
- Locked
- Detected Nov 19, 2026, 8:47 AM ETPrimary completion dateNCT07204418A Study to Evaluate the Effects of CYP2D6 Phenotypes on the Pharmacokinetics of Xanomeline Following KarXT Administration in Healthy...BMY
- Now
- Sep 28, 2026 (actual)
- Before
- Locked
- Detected Nov 19, 2026, 8:47 AM ETStatusNCT07204418A Study to Evaluate the Effects of CYP2D6 Phenotypes on the Pharmacokinetics of Xanomeline Following KarXT Administration in Healthy...BMY
- Now
- Completed
- Before
- Locked
The previous value and the sponsor's record update date are locked on 25 rows here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.
Unlock with TrialScannerShowing the first 25 changes. There are 409 more in this window; the full list is part of TrialScanner.
Unlock with TrialScannerTracking since Nov 12, 2026. Changes before that date are not known to TrialScanner.
What is on this list
Changes Signal8 recorded between two refreshes of a trial's ClinicalTrials.gov record: status, primary completion and completion dates, and results first posted. A change is shown when it was detected, which can be days after the sponsor updated the record. Nothing here describes what a trial showed.
New registrations, enrollment, eligibility and outcome-measure edits are not recorded. A status change is the registry's own word for where the trial stands, and "results posted" means results were posted to the registry, never what they show.
Free readers see the first 25 changes of any filter with the new value. The previous value, the sponsor's record update date and later pages are part of the plan. See the methodology.